Powered by
Read the full press release here A planned trial of a COVID-19 vaccine is restarting at UW-Health. That drug trial, run by AstraZeneca and Oxford University, was halted last week after a participant in the United Kingdom had an adverse…
Read the full press release here Waisman Biomanufacturing at the University of Wisconsin–Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by California-based biotech company GigaGen. The drug, called GIGA-2050, uses a new approach similar to…
Read the full story here As if we didn’t have enough troubles with COVID-19 still very active throughout the country, flu season is just a month or two away. Americans have grown complacent about flu; vaccination rates hover below 50%.…
Read the full press release here UW Health University Hospital in Madison is one of the test sites for a phase 3 trial of an experimental vaccine for COVID-19, and researchers are trying to recruit a diverse group of people…
Read the full press release here Exact Sciences has won regulatory approval to process COVID-19 tests from specimens taken by people in their homes. The Food and Drug Administration gave approval for the company to test specimens collected using two…